why choose us

First received: March 29, 2023

Clinical Trial: Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: HPV Associated Cancers

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Trial of TGN-S11 in Patients With Human Papillomavirus (HPV)-Associated Relapsed, Resistant or Metastatic Cancer

Brief Summary: This is an open-label, non-randomized, Phase I, dose escalation/dose expansion study in cohorts of patients with relapsed, resistant, or metastatic HPV-associated cancers.The Expansion Phase will begin in parallel one dose level lower than the highest dose deemed safe in the Dose Escalation in combination with a PD-1 checkpoint blockade.

Read more